Navigation Links
Boston Scientific Announces Schedule of Events at TCT Scientific Symposium
Date:11/1/2011

#160;Presentations will examine clinical data from challenging PCI subsets and preview new research on bioabsorbable drug delivery from the EVOLVE trial.
  • REPRISE Clinical Program for Lotus™ Valve System.  Ian Meredith, M.B.B.S., Ph.D., will present an update on the REPRISE clinical program, which is evaluating the Lotus™ Valve System, the first fully repositionable device for percutaneous aortic valve replacement to treat patients with severe aortic stenosis.  The Lotus Valve was developed by Sadra Medical, acquired by Boston Scientific in 2011.  The spotlight session begins at 8:58 a.m. in Room 135.  

  • Friday, November 11

  • Late-Breaking Trial: EVOLVE Endpoint Data.  Principal Investigator Ian Meredith, M.B.B.S., Ph.D., will present primary endpoint data from the EVOLVE trial during a late-breaking clinical session at 11 a.m. in the Main Arena.  EVOLVE is a prospective, randomized, non-inferiority trial that compares two dose formulations of everolimus on Boston Scientific's SYNERGY Coronary Stent to the PROMUS Element Everolimus-Eluting Coronary Stent in patients with de novo coronary artery lesions.  The SYNERGY Stent features the Company's proprietary platinum chromium alloy and uses a bioabsorbable polymer and everolimus drug combination to create an ultra-thin, uniform coating confined to the outer surface of the stent.  The Company plans to issue a press release announcing trial results at the conclusion of the presentation.

  • Late-Breaking Trial: COBRA Endpoint Data.   Subhash Banerjee, M.D., will present 12-month endpoint data from the COBRA trial during a late-breaking clinical session at 12:40 p.m. in the Main Arena.  COBRA is a prospective, randomized, multi-center trial that compares CryoPlasty® Therapy using the PolarCath™ Peripheral Dilatation System to conventional balloon angioplasty for the post-dilatation of
    '/>"/>

  • SOURCE Boston Scientific Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
    2. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
    3. Boston University Biomedical Engineers Find Chink in Bacterias Armor
    4. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
    5. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
    6. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
    7. Boston Scientifics Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
    8. Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial
    9. Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results
    10. Award-Winning Medicine Wheel Returns to the Cyclorama at the Boston Center for the Arts on Dec. 1 for 24-hour Vigil Recognizing World AIDS Day
    11. Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/26/2015)... -- "Whether it,s our family, our friends, all of ... a single sentence, Dr. Anthony Coyle , senior ... Centers for Therapeutic Innovation (CTI), sums up what ... biopharmaceutical companies. CTI,s unique model allows ... and the National Institutes of Health (NIH) to bridge ...
    (Date:3/26/2015)... YORK , March 26, 2015 ... the average American consumer. However, a new survey ... various ailments from the common cold to diabetes, ... The research, conducted by the Private Label ... on over-the-counter healthcare products, including those essential for ...
    (Date:3/26/2015)... Research and Markets ( ... "Global Smart Wearable Healthcare Devices and Services ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The analysts forecast ... market to grow at a CAGR of 30.42% ... covers the present scenario and the growth prospects ...
    Breaking Medicine Technology:Collaboration for Cures: Teaming Up to Advance Science and Save Lives 2Consumers can keep over-the-counter medicine affordable by using store brands 2Global Smart Wearable Healthcare Devices and Services Market 2015-2019 WITH Apple, At&T, Ee, Google, Samsung, Sprint, Telefonica & T-Mobile Dominating 2
    ... WOODCLIFF LAKE, N.J., Nov. 3, 2010 Par Pharmaceutical Companies, ... the third quarter ended September 30, 2010. For ... total revenues of $234.4 million and income from continuing operations ... included a $2.0 milestone payment to Tris Pharma, Inc., a ...
    ... 2010 Regado Biosciences, Inc., a privately held company ... agents, announced that Steven L. Zelenkofske, D.O., F.A.C.C., Senior ... at the American College of Chest Physicians (ACCP) Coagulation ... Vancouver, BC, Canada.  The abstract is titled "Sustained Inhibition ...
    Cached Medicine Technology:Par Pharmaceutical Companies Reports Third Quarter 2010 Results 2Par Pharmaceutical Companies Reports Third Quarter 2010 Results 3Par Pharmaceutical Companies Reports Third Quarter 2010 Results 4Par Pharmaceutical Companies Reports Third Quarter 2010 Results 5Par Pharmaceutical Companies Reports Third Quarter 2010 Results 6Par Pharmaceutical Companies Reports Third Quarter 2010 Results 7Par Pharmaceutical Companies Reports Third Quarter 2010 Results 8Par Pharmaceutical Companies Reports Third Quarter 2010 Results 9Par Pharmaceutical Companies Reports Third Quarter 2010 Results 10Par Pharmaceutical Companies Reports Third Quarter 2010 Results 11Regado Biosciences, Inc. Presents the First-In-Human Clinical Experience with REG2 at the American College of Chest Physicians (ACCP) Coagulation and Heart Disease Sessions in Vancouver, BC, Canada on November 2, 2010 2Regado Biosciences, Inc. Presents the First-In-Human Clinical Experience with REG2 at the American College of Chest Physicians (ACCP) Coagulation and Heart Disease Sessions in Vancouver, BC, Canada on November 2, 2010 3
    (Date:3/27/2015)... March 27, 2015 “ VXi BlueParott ... its monthly Tech Report, which features the latest and ... technology expert and special reporter for NewsWatch, conducted the ... advanced noise-cancelling headset, eliminating 90% of ambient noise. , ... texts and emails are important to any professional, voice ...
    (Date:3/27/2015)... In light of two lawsuits that ... District Court, District of Massachusetts; and case number 2:15-cv-00709PD, ... Pennsylvania), the San Diego personal injury lawyers of The ... that they are available to investigate potential birth ... prescribed Zofran while pregnant and who gave birth to ...
    (Date:3/26/2015)... (PRWEB) March 26, 2015 Elfster.com, the ... addition of its bucket list generator capabilities to its ... course, refers to a list that one creates of ... the 2007 movie of the same name. Nowadays ... way to memorialize their summer achievements. , "We are ...
    (Date:3/26/2015)... San Diego (PRWEB) March 26, 2015 ... to advance health and wellness for the poor and ... the application period for its annual $1 million award, ... is excited to announce the 2015 round of our ... "We've seen and supported some incredibly creative and ambitious ...
    (Date:3/26/2015)... 26, 2015 The American College of Traditional ... the topics of the DAOM Program as well as Marketing ... Webinar will be hosted by Dr. Carla Wilson, who will ... steps on how to prepare for the spring quarter. The ... March 27, April 1 and April 3. Attendees can log ...
    Breaking Medicine News(10 mins):Health News:A Device to Tune out Background Noise was Recently Featured on NewsWatch Television 2Health News:The Law Office of Melinda J. Helbock, A.P.C. Announces That It Is Now Accepting Case Reviews for Potential Zofran Birth Defect Lawsuits 2Health News:Plans for Bucket List Generator - Just In Time for Summer - Announced by Elfster 2Health News:Applications Open for $1M Innovation Initiative Award from Alliance Healthcare Foundation 2Health News:ACTCM Announces Upcoming Webinars 2
    ... Cellmark Inc.,(Nasdaq: ORCH ), a leading worldwide provider ... for the fourth quarter and,full year of 2007., ... the fourth,quarter of 2007 compared to $14.9 million for ... 2007, revenues were $60.3 million compared to $56.9,million for ...
    ... The International,Society for CNS Clinical Trials ... in Washington, DC, February 25-27. This organization,involves ... of the pharmaceutical industry, and governmental,drug-regulatory bodies ... safety,of drugs used to treat psychiatric and ...
    ... Health Net,s Roger and Erika Greaves; CNN,s ... of Humanity Award, SHERMAN OAKS, Calif., March 5 ... prevent pediatric,burns and to heal severely burned children, celebrated its ... on Feb. 21. The event,was attended by more than 700 ...
    ... N.J., March 5 Besler,& Company, Inc., a ... agreed to pay the United States $2.875 million, ... federal Medicare program, the,Justice Department announced today., ... company counseled hospital clients to improperly,increase charges to ...
    ... ten elderly adults on Medicare reports drinking more alcohol ... Brandeis University. , Even though alcohol problems are ... older adults are consuming alcohol in amounts that exceed ... at Brandeis Universitys Heller School for Social Policy and ...
    ... Answer That Question, BREA, Calif., March 5 ... site in the United States, now,helps pet owners ... are with a quick and humorous online Canine ... gauges pet owner,responses to determine their dog,s brain ...
    Cached Medicine News:Health News:Orchid Cellmark Reports Fourth Quarter and Full Year 2007 Financial Results 2Health News:Orchid Cellmark Reports Fourth Quarter and Full Year 2007 Financial Results 3Health News:Orchid Cellmark Reports Fourth Quarter and Full Year 2007 Financial Results 4Health News:Orchid Cellmark Reports Fourth Quarter and Full Year 2007 Financial Results 5Health News:Orchid Cellmark Reports Fourth Quarter and Full Year 2007 Financial Results 6Health News:Orchid Cellmark Reports Fourth Quarter and Full Year 2007 Financial Results 7Health News:Orchid Cellmark Reports Fourth Quarter and Full Year 2007 Financial Results 8Health News:Orchid Cellmark Reports Fourth Quarter and Full Year 2007 Financial Results 9Health News:FDA Warning of Suicidal Risk Associated with Antidepressants in Juveniles and Young Adults Reviewed at Recent ISCTM Meeting 2Health News:Children's Burn Foundation's Benefit Raises More Than $875,000 for Burn Survivors and Prevention 2Health News:Children's Burn Foundation's Benefit Raises More Than $875,000 for Burn Survivors and Prevention 3Health News:New Jersey Healthcare Consulting Firm to Pay U.S. $2.875 Million to Resolve Allegations of Medicare Fraud 2Health News:New study sheds light on excessive drinking among the elderly 2Health News:Is Your Dog a Canine-stein or a Bonehead? 2Health News:Is Your Dog a Canine-stein or a Bonehead? 3
    ... Cycler is Thermo Electron's most advanced personal ... easy to use sophisticated onboard software and ... Designed to offer performance, accuracy and simplicity ... number of customer driven features built up ...
    ... Design With Exceptional Performance The ... interface might be the first ... MyCycler is designed for performance. ... a premium, its small footprint ...
    96 well thermocycler with unique High Temperature Range (HTR) Peltier technology for fastest available heating and cooling rates up to 4C/sec with High Pressure Lid for automated sealing of PCR plate...
    ... Faster speeds, highest precision, more user-friendliness ... concept: this is the definition of the ... years nucleic acid research has been developing ... required of PCR Systems. To keep ...
    Medicine Products: